Junmin Li

7.5k total citations
189 papers, 3.5k citations indexed

About

Junmin Li is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Junmin Li has authored 189 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Hematology, 69 papers in Molecular Biology and 40 papers in Oncology. Recurrent topics in Junmin Li's work include Acute Myeloid Leukemia Research (53 papers), Lymphoma Diagnosis and Treatment (24 papers) and Retinoids in leukemia and cellular processes (22 papers). Junmin Li is often cited by papers focused on Acute Myeloid Leukemia Research (53 papers), Lymphoma Diagnosis and Treatment (24 papers) and Retinoids in leukemia and cellular processes (22 papers). Junmin Li collaborates with scholars based in China, United States and Switzerland. Junmin Li's co-authors include Sai‐Juan Chen, Zhixiang Shen, Jian‐Qing Mi, Wen Wu, Samuel Waxman, Wenbin Xu, Yang Shen, Zhu Chen, Yongmei Zhu and Jiong Hu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Chemical Physics.

In The Last Decade

Junmin Li

172 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junmin Li China	32	1.9k	1.2k	662	432	384	189	3.5k
Javier Corral Spain	37	1.4k 0.8×	2.7k 2.1×	328 0.5×	151 0.3×	507 1.3×	235	5.2k
Mark J. Koury United States	40	1.9k 1.0×	2.1k 1.7×	532 0.8×	123 0.3×	346 0.9×	123	5.5k
Joseph R. Slupsky United Kingdom	29	1.5k 0.8×	984 0.8×	581 0.9×	366 0.8×	321 0.8×	61	4.2k
Jung‐Shin Lee South Korea	31	2.4k 1.3×	514 0.4×	1.4k 2.2×	266 0.6×	376 1.0×	110	4.8k
Yasushi Miyazaki Japan	34	1.4k 0.7×	2.3k 1.9×	790 1.2×	336 0.8×	240 0.6×	254	5.0k
P. Maslak United States	32	2.8k 1.5×	1.7k 1.4×	3.1k 4.6×	658 1.5×	300 0.8×	116	6.3k
Wolfgang Bergmeier United States	47	1.5k 0.8×	3.4k 2.8×	494 0.7×	185 0.4×	329 0.9×	139	6.8k
Francis Lacombe France	28	948 0.5×	952 0.8×	448 0.7×	188 0.4×	214 0.6×	82	2.4k
Piotr Smolewski Poland	32	1.8k 1.0×	446 0.4×	815 1.2×	651 1.5×	317 0.8×	172	3.5k
Boris Bigalke Germany	37	1.3k 0.7×	1.1k 0.9×	749 1.1×	104 0.2×	299 0.8×	137	6.1k

Countries citing papers authored by Junmin Li

Since Specialization

Citations

This map shows the geographic impact of Junmin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junmin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junmin Li more than expected).

Fields of papers citing papers by Junmin Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junmin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junmin Li. The network helps show where Junmin Li may publish in the future.

Co-authorship network of co-authors of Junmin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Junmin Li. A scholar is included among the top collaborators of Junmin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junmin Li. Junmin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xin, et al.. (2025). Mechanisms of synergistic regulation on friction and wear performance of SUS304 stainless steel by DLC coatings and laser-textured dimple morphologies. Surface and Coatings Technology. 516. 132718–132718.

Jin, Wen, Yuting Dai, Li Chen, et al.. (2024). Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia. Nature Communications. 15(1). 6 indexed citations

Yang, Wei, Sujun Gao, Xiaojing Yan, et al.. (2024). Latest results of a phase 2 study of IMM01 combined with azacitidine (AZA) as the first-line treatment in adults with higher risk myelodysplastic syndromes (MDS).. Journal of Clinical Oncology. 42(16_suppl). 6510–6510.

Wolf, Steven, Jesse D. Troy, Huimin Wang, et al.. (2024). Moving beyond “Better Late than Never”: High Symptom Burden and Diminished Functional Status at First Palliative Care Visit for Patients with Gynecological Cancers. Journal of Palliative Medicine. 27(9). 1204–1209.

Sun, Ju, Tianyi Zheng, Mingjun Jia, et al.. (2024). Dual receptor-binding, infectivity, and transmissibility of an emerging H2N2 low pathogenicity avian influenza virus. Nature Communications. 15(1). 10012–10012. 3 indexed citations

Ouyang, Yan, Huan Li, Chunyan Qiao, et al.. (2024). Effect of therapeutic erythrocytapheresis on outcomes and renal benefit in patients with high-altitude polycythemia: a real-world study. Scientific Reports. 14(1). 29081–29081. 1 indexed citations

Li, Ran, Xiaolu Wu, Kai Xue, et al.. (2023). RNA demethylase ALKBH5 promotes tumorigenesis of t (8;21) acute myeloid leukemia via ITPA m6A modification. Biomarker Research. 11(1). 30–30. 11 indexed citations

Tong, Hongyan, Sujun Gao, Wei Yang, et al.. (2023). Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Chronic Myelomonocytic Leukemia (CMML). Blood. 142(Supplement 1). 1859–1859. 4 indexed citations

Wang, Yanjun, Yanqun Song, Zhongcheng Liu, et al.. (2023). miR‑149‑3p suppresses the proliferation and metastasis of glioma cells by targeting the CBX2/Wnt/β‑catenin pathway. Experimental and Therapeutic Medicine. 26(6). 562–562. 2 indexed citations

10.

Yu, Jingjing, Weikang Huang, Junmin Li, et al.. (2023). Extracellular HSP90 promotes differentiation of lens epithelial cells to fiber cells by activating LRP1‐YAP‐PROX1 axis. The FASEB Journal. 37(2). e22783–e22783. 2 indexed citations

11.

Li, Junmin, et al.. (2023). [Maintenance of efficacy and its predictors after discontinuation of eltrombopag in adults with primary immune thrombocytopenia].. PubMed. 44(1). 32–37. 1 indexed citations

12.

Huang, Xuan, Junmin Li, Xiaoying Pang, et al.. (2023). Gene polymorphism and prediction of toxicity to platinum‐based chemotherapy in patients with gynecologic cancer. Clinical and Translational Science. 16(12). 2519–2529. 2 indexed citations

13.

Jin, Peng, Xiaoling Wang, Ming Zhao, et al.. (2022). Large-Scale In Vitro and In Vivo CRISPR-Cas9 Knockout Screens Identify a 16-Gene Fitness Score for Improved Risk Assessment in Acute Myeloid Leukemia. Clinical Cancer Research. 28(18). 4033–4044. 10 indexed citations

14.

Niu, Q. L., Yang Shen, Hai Fang, et al.. (2021). Integration of Genomic and Transcriptomic Markers Improves the Prognosis Prediction of Acute Promyelocytic Leukemia. Clinical Cancer Research. 27(13). 3683–3694. 15 indexed citations

15.

Hu, Yu, Jie Jin, Yujie Zhang, et al.. (2021). [Venetoclax with low-dose cytarabine for patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy: results from the Chinese cohort of a phase three randomized placebo-controlled trial].. PubMed Central. 42(4). 288–294. 4 indexed citations

16.

Hu, Xuejiao, Qianyun Deng, Junmin Li, et al.. (2020). Development and Clinical Application of a Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for SARS-CoV-2 Infection. mSphere. 5(4). 52 indexed citations

17.

Sun, Huiping, et al.. (2019). [Efficacy and safety of recombinant human thrombopoietin in adult patients with primary immune thrombocytopenia during the perioperative period].. PubMed Central. 40(3). 191–194. 1 indexed citations

18.

Yassin, Mohamed A., Alì Taher, Vikram Mathews, et al.. (2018). Myeloproliferative Neoplasms in Asia, Including Middle East, Turkey, and Algeria: Epidemiological Indices and Treatment Practice Patterns from the Multinational, Multicenter, Observational MERGE Registry. Blood. 132(Supplement 1). 5461–5461. 2 indexed citations

19.

Angelucci, Emanuele, Junmin Li, Peter L. Greenberg, et al.. (2018). Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study. Blood. 132(Supplement 1). 234–234. 24 indexed citations

20.

Chen, Juan, Li Zhou, Hongying Lu, et al.. (2015). [Efficacy and safety of generic imatinib mesylate capsules produced in China for newly diagnosed chronic myeloid leukemia in chronic phase patients].. PubMed. 36(3). 235–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact